Bradshaw

UK private companies, understood.

Ask the question your job turns on. Bradshaw answers from every share allotment, set of accounts, grant, contract and ownership record on the public register.

Which life sciences companies raised at a higher price than their last round this year?

11up rounds in 2026median step-up 1.7x

Filters

  • Life sciences and health
  • Up round
  • Allotted in 2026

Bar: step-up

  • Zonova Technologies Ltd4.0x step-up · £5.5m post-money
  • Basecamp Research Ltd3.2x step-up · £537.5m post-money
  • Rivan Industries Ltd2.4x step-up · £79.6m post-money

From Companies House filings, Innovate UK awards and public contract notices. Data to 16 Oct 2026.

Early access opens soon. Read how Bradshaw works in the meantime. Read the blog

Opening November 2026. 14-day free trial, no card.

What Bradshaw does for you

Three jobs, one product: find the right companies, understand what they are worth, and act when something changes.

Discover

Find the companies that matter

Search 5.7m UK companies by sector, region, funding, financials and ownership. Signals flag the moments that matter: a first priced round after an Innovate UK grant, an up round, a round priced below the last, a major overseas corporate shareholder.

Signals since 1 Jan 2024

  • 556Grant, then equityFirst priced round came after an Innovate UK award.
  • 220Up roundsPriced above the company's previous priced round.
  • 88Priced below the lastPriced below the company's previous priced round.
  • 72Overseas corporate shareholderRaised, and an overseas company has significant control.

Companies for grant then equity and overseas corporate shareholder, rounds for the other two, with a priced round allotted since 1 Jan 2024. Data to 16 Oct 2026.

See who owns what

Corporate shareholders, parent companies and the investors behind each round, drawn as a network you can explore.

Oxford Science Enterprises

Active holding
Oxford Science Enterprises18 funded companies
Network map: Oxford Science Enterprises at the centre with 12 portfolio companies around it and 0 other corporate holders linked to them.
NameRoleDetail
Oxford Science EnterprisesInvestor18 funded companies
Snowfox Discovery LtdCompanyActive holding, raised £11.9m
Cora Biosciences LimitedCompanyActive holding, raised £11.2m
Natural Capital Research LimitedCompanyActive holding, raised £10.7m
Archangel Lightworks LtdCompanyActive holding, raised £10.7m
Fluorok LimitedCompanyActive holding, raised £7.75m
Acionna Therapeutics LtdCompanyActive holding, raised £7.50m
Vivid DX LimitedCompanyActive holding, raised £6.66m
Seloxium LimitedCompanyActive holding, raised £5.88m
Kodiform Therapeutics LimitedCompanyActive holding, raised £5.00m
Marley Health LtdCompanyActive holding, raised £4.65m
Ascension Earth Resources LtdCompanyActive holding, raised £4.50m
Dyna Therapeutics LimitedCompanyActive holding, raised £3.50m

Dot size is money raised since 1 January 2024. A line means the register shows that holder for that company.

12 of 18 companies with an active corporate shareholding that raised a priced round since 1 Jan 2024, by money raised. Data to 16 Oct 2026.

Map a market

Where equity is being raised, by region and sector, and how each compares.

Priced rounds by region

Priced rounds by region since 1 Jan 2024: London 1,481; South East 354; East of England 270; North West 225; South West 175; Scotland 169; Yorkshire and the Humber 110; West Midlands 81; Wales 78; East Midlands 69; Northern Ireland 47; North East 40.
NameValueDetail
London1,481£9.52bn raised
South East354£3.80bn raised
East of England270£2.19bn raised
North West225£744m raised
South West175£1.01bn raised
Scotland169£440m raised
Yorkshire and the Humber110£583m raised
West Midlands81£301m raised
Wales78£122m raised
East Midlands69£142m raised
Northern Ireland47£92.6m raised
North East40£60.6m raised

Priced rounds allotted since 1 Jan 2024 by the region of the registered office postcode; cash raised beside each count. Data to 16 Oct 2026.

Value

Benchmark any price

Pre-money valuations by sector from every priced round, so you can see where a price sits before you negotiate.

What UK companies are worth

Pre-money valuation by sector, 9 groups, on a log scale: Business services median £10.5m, n=339; Energy and climate median £10.0m, n=34; Deep tech and hardware median £9.79m, n=281; Consumer, food and retail median £9.01m, n=244; Fintech and financial services median £7.99m, n=96; Software and IT median £7.60m, n=1,365; and 3 more.
GroupRounds10thLower quartileMedianUpper quartile90th
Business services339£1.11m£2.53m£10.5m£24.9m£83.3m
Energy and climate34£344k£2.49m£10.0m£17.5m£34.5m
Deep tech and hardware281£2.00m£4.53m£9.79m£21.1m£52.3m
Consumer, food and retail244£816k£2.96m£9.01m£20.6m£45.7m
Fintech and financial services96£239k£2.68m£7.99m£26.1m£114m
Software and IT1,365£1.42m£3.00m£7.60m£21.3m£50.4m
Life sciences and health342£1.49m£3.29m£7.51m£21.5m£42.9m
Media, creative and leisure60£712k£2.32m£5.29m£15.2m£44.1m
Property and construction42£96k£346k£2.23m£12.2m£30.7m

Box is the middle half of rounds, the line inside it the median, whiskers the 10th to 90th percentile. Log scale.

Pre-money valuation on an issued-share basis. Priced rounds allotted since 1 Jan 2024. Data to 16 Oct 2026.

Know what a company is worth

The price per share and valuation from every priced round, the step-up from the last, and where it sits against its sector.

Isomorphic Labs Limited: price per share, round by round

Bar height is on a log scale.

Price per share by round: 3 Sep 2024 £1.656; 31 Mar 2025 £4.7415; 12 Jun 2026 £12.7203.
Round allottedPrice per shareAgainst previous round
3 Sep 2024£1.656n/a
31 Mar 2025£4.74152.9x
12 Jun 2026£12.72032.7x

3 priced rounds allotted since 1 Jan 2024 at confidence 0.50 or higher; the multiple is the price against the previous round. Data to 16 Oct 2026.

Read the numbers behind the story

Balance sheets from filed accounts, year by year, next to the funding that paid for them.

Jet Engineering System Solutions Ltd: cash and net assets

  • Cash
  • Net assets
Cash and net assets by balance sheet date. 31 Dec 2021: Cash £49k, Net assets £75k; 31 Dec 2022: Cash £102k, Net assets £177k; 31 Dec 2023: Cash £141k, Net assets £1.18m; 31 Dec 2024: Cash £57k, Net assets £1.29m; 31 Dec 2025: Cash £188k, Net assets £2.01m.
Balance sheet dateCashNet assets
31 Dec 2021£49k£75k
31 Dec 2022£102k£177k
31 Dec 2023£141k£1.18m
31 Dec 2024£57k£1.29m
31 Dec 2025£188k£2.01m

Cash and net assets as filed for the last 5 balance sheet dates; a figure a filing does not tag shows as not filed. Data to 16 Oct 2026.

Act

Stay ahead of every change

Save a search, follow a list and get an email when something changes. Take any view out as CSV, or call the same filters from the API.

  • Alerts

    Daily emails when a saved search or a list changes.

  • Export

    Any view to CSV, with the same columns you see.

  • API

    The same filters and figures by code, for your CRM, models and dashboards.

Built for the people who back, buy and advise UK companies

Get early access

Bradshaw opens in November 2026. Join the list and we will email you the day it does.

Early access opens soon. Read how Bradshaw works in the meantime. Read the blog